• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients.

作者信息

Ramos Laura, Hernández-Porto Miriam, Carrillo-Palau Marta, Alonso-Abreu Inmaculada, Reygosa Cristina, Hernandez-Guerra Manuel

机构信息

Gastroenterology and Hepatology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain.

Microbiology Department, Hospital Universitario de Canarias, Tenerife, Spain.

出版信息

Inflamm Bowel Dis. 2023 Jul 5;29(7):1165-1169. doi: 10.1093/ibd/izac228.

DOI:10.1093/ibd/izac228
PMID:36321900
Abstract
摘要

相似文献

1
Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients.生物制剂对炎症性肠病患者额外剂量的SARS-CoV-2疫苗诱导的免疫反应的影响。
Inflamm Bowel Dis. 2023 Jul 5;29(7):1165-1169. doi: 10.1093/ibd/izac228.
2
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial.研究癌症患者接种第三和第四剂 COVID-19 疫苗的免疫反应效果和持久性：一项单臂临床试验。
Elife. 2023 Mar 28;12:e83694. doi: 10.7554/eLife.83694.
3
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
4
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.养老院居民中初次接种和加强接种 SARS-CoV-2 信使 RNA 疫苗后的 T 细胞介导的反应。
J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.
5
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease.抗肿瘤坏死因子治疗与炎症性肠病患者对 SARS-CoV-2 疫苗的体液免疫应答减弱相关。
Vaccine. 2023 Jun 13;41(26):3862-3871. doi: 10.1016/j.vaccine.2023.05.012. Epub 2023 May 8.
6
Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?免疫抑制治疗的炎症性肠病患者接种 SARS-CoV-2 疫苗后的体液免疫原性：我们是否应该优先考虑额外加强注射？
Inflamm Bowel Dis. 2023 Feb 1;29(2):268-273. doi: 10.1093/ibd/izac187.
7
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments.在接受抗TNF或其他治疗的炎症性肠病患者中，接种三剂新冠疫苗后产生强大的新冠病毒抗体和T细胞免疫。
Gut. 2024 Mar 7;73(4):712-714. doi: 10.1136/gutjnl-2022-329136.
8
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases.免疫介导的炎症性疾病患者对 SARS-CoV-2 mRNA 疫苗的免疫应答迅速减弱。
JCI Insight. 2022 Jun 8;7(11):e159721. doi: 10.1172/jci.insight.159721.
9
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan.KD-414 新冠灭活疫苗在成年人中的单剂加强免疫的免疫原性和安全性：日本一项开放标签、单中心、非随机、对照研究。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2193074. doi: 10.1080/21645515.2023.2193074. Epub 2023 Apr 13.
10
[Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?].[灭活新型冠状病毒疫苗的体液免疫反应：何时应接种加强针？]
Mikrobiyol Bul. 2022 Jul;56(3):566-573. doi: 10.5578/mb.20229715.

引用本文的文献

1
Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients.硫嘌呤治疗的炎症性肠病患者对SARS-CoV-2疫苗的长期定量细胞反应受损。
Cells. 2025 Jul 26;14(15):1156. doi: 10.3390/cells14151156.
2
Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease.儿童炎症性肠病中SARS-CoV-2疫苗接种后12个月抗体反应的持久性
Vaccines (Basel). 2025 May 22;13(6):549. doi: 10.3390/vaccines13060549.
3
Efficacy of COVID-19 vaccines in inflammatory bowel disease patients receiving -TNF therapy: A systematic review and meta-analysis.
新冠病毒疫苗在接受肿瘤坏死因子治疗的炎症性肠病患者中的疗效：一项系统评价和荟萃分析。
Heliyon. 2023 Sep 5;9(9):e19609. doi: 10.1016/j.heliyon.2023.e19609. eCollection 2023 Sep.